4//SEC Filing
Praill Anthony Scott 4
Accession 0001213900-20-016319
CIK 0001498382other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:17 PM ET
Size
7.6 KB
Accession
0001213900-20-016319
Insider Transaction Report
Form 4
Praill Scott
CFO
Transactions
- Award
Option (Right to Buy)
2020-06-26+57,170→ 108,366 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (57,170 underlying) - Other
Common Stock
2020-06-30+22→ 7,474 total
Footnotes (3)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
- [F2]On September 5, 2019, the reporting person received options to purchase 57,170 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020.
- [F3]1/6th of the options vested on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months which commenced on April 5, 2020.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001332948
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:17 PM ET
- Size
- 7.6 KB